1.
Comella P, Casaretti R, Manzo R, Sandomenico C, Licenziato M, Avallone A, et al. Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet. AO [Internet]. 2010 Jan. 1 [cited 2026 May 22];49(1):50-6. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32343